190 related articles for article (PubMed ID: 37456582)
1. Activation of autophagy by
Yang Y; Zhu Y; Wang K; Miao Y; Zhang Y; Gao J; Qin H; Zhang Y
Bioact Mater; 2023 Nov; 29():116-131. PubMed ID: 37456582
[TBL] [Abstract][Full Text] [Related]
2. Enhanced Tumor-Specific Disulfiram Chemotherapy by
Wu W; Yu L; Jiang Q; Huo M; Lin H; Wang L; Chen Y; Shi J
J Am Chem Soc; 2019 Jul; 141(29):11531-11539. PubMed ID: 31251050
[TBL] [Abstract][Full Text] [Related]
3. Silk Fibroin-Modified Disulfiram/Zinc Oxide Nanocomposites for pH Triggered Release of Zn
Zhao YZ; Lin MT; Lan QH; Zhai YY; Xu HL; Xiao J; Kou L; Yao Q
Mol Pharm; 2020 Oct; 17(10):3857-3869. PubMed ID: 32833457
[TBL] [Abstract][Full Text] [Related]
4. Copper-Enriched Prussian Blue Nanomedicine for In Situ Disulfiram Toxification and Photothermal Antitumor Amplification.
Wu W; Yu L; Pu Y; Yao H; Chen Y; Shi J
Adv Mater; 2020 Apr; 32(17):e2000542. PubMed ID: 32162734
[TBL] [Abstract][Full Text] [Related]
5. An In Situ Chemotherapy Drug Combined with Immune Checkpoint Inhibitor for Chemoimmunotherapy.
Yuan X; Wang X
Nanomaterials (Basel); 2023 Dec; 13(24):. PubMed ID: 38133040
[TBL] [Abstract][Full Text] [Related]
6.
Hou L; Liu Y; Liu W; Balash M; Zhang H; Zhang Y; Zhang H; Zhang Z
Acta Pharm Sin B; 2021 Jul; 11(7):2016-2030. PubMed ID: 34386335
[TBL] [Abstract][Full Text] [Related]
7. Disulfiram-loaded metal organic framework for precision cancer treatment via ultrasensitive tumor microenvironment-responsive copper chelation and radical generation.
Zhang H; Zhang Q; Guo Z; Liang K; Boyer C; Liu J; Zheng Z; Amal R; Yun SLJ; Gu Z
J Colloid Interface Sci; 2022 Jun; 615():517-526. PubMed ID: 35152072
[TBL] [Abstract][Full Text] [Related]
8. Damage-associated molecular patterns (DAMPs) related to immunogenic cell death are differentially triggered by clinically relevant chemotherapeutics in lung adenocarcinoma cells.
Solari JIG; Filippi-Chiela E; Pilar ES; Nunes V; Gonzalez EA; Figueiró F; Andrade CF; Klamt F
BMC Cancer; 2020 May; 20(1):474. PubMed ID: 32456685
[TBL] [Abstract][Full Text] [Related]
9. Induction of immunogenic cell death in radiation-resistant breast cancer stem cells by repurposing anti-alcoholism drug disulfiram.
Sun T; Yang W; Toprani SM; Guo W; He L; DeLeo AB; Ferrone S; Zhang G; Wang E; Lin Z; Hu P; Wang X
Cell Commun Signal; 2020 Mar; 18(1):36. PubMed ID: 32138738
[TBL] [Abstract][Full Text] [Related]
10. Tailor-Made Autophagy Cascade Amplification Polymeric Nanoparticles for Enhanced Tumor Immunotherapy.
Long X; Wang H; Yan J; Li Y; Dong X; Tian S; Sun Y; Luo K; He B; Liang Y
Small; 2023 Jun; 19(24):e2207898. PubMed ID: 36932938
[TBL] [Abstract][Full Text] [Related]
11. Glutathione-responsive copper-disulfiram nanoparticles for enhanced tumor chemotherapy.
Chen M; Huang Z; Xia M; Ding Y; Shan T; Guan Z; Dai X; Xu X; Huang Y; Huang M; Zhao C
J Control Release; 2022 Jan; 341():351-363. PubMed ID: 34856225
[TBL] [Abstract][Full Text] [Related]
12. Enhanced pH-Responsive Chemo/Chemodynamic Synergistic Cancer Therapy Based on In Situ Cu
Zhou M; Tian B; Bu Y; Wu Z; Yu J; Wang S; Sun X; Zhu X; Zhou H
ACS Appl Bio Mater; 2023 Aug; 6(8):3221-3231. PubMed ID: 37428493
[TBL] [Abstract][Full Text] [Related]
13. Tumor Microenvironment-Activatable Prodrug Vesicles for Nanoenabled Cancer Chemoimmunotherapy Combining Immunogenic Cell Death Induction and CD47 Blockade.
Zhou F; Feng B; Yu H; Wang D; Wang T; Ma Y; Wang S; Li Y
Adv Mater; 2019 Apr; 31(14):e1805888. PubMed ID: 30762908
[TBL] [Abstract][Full Text] [Related]
14. Engineered exosomes as an in situ DC-primed vaccine to boost antitumor immunity in breast cancer.
Huang L; Rong Y; Tang X; Yi K; Qi P; Hou J; Liu W; He Y; Gao X; Yuan C; Wang F
Mol Cancer; 2022 Feb; 21(1):45. PubMed ID: 35148751
[TBL] [Abstract][Full Text] [Related]
15. Disulfiram loaded calcium phosphate nanoparticles for enhanced cancer immunotherapy.
Li Q; Chao Y; Liu B; Xiao Z; Yang Z; Wu Y; Liu Z
Biomaterials; 2022 Dec; 291():121880. PubMed ID: 36334355
[TBL] [Abstract][Full Text] [Related]
16. Disulfiram/Copper Induces Immunogenic Cell Death and Enhances CD47 Blockade in Hepatocellular Carcinoma.
Gao X; Huang H; Pan C; Mei Z; Yin S; Zhou L; Zheng S
Cancers (Basel); 2022 Sep; 14(19):. PubMed ID: 36230638
[TBL] [Abstract][Full Text] [Related]
17. Tandem Chemoimmunotherapy by a Cascade-Responsive Molecular Prodrug.
Yang Z; Luo X; Lin Y; Huang J; Lin H; Gao J
ACS Chem Biol; 2022 Apr; 17(4):762-767. PubMed ID: 35285234
[TBL] [Abstract][Full Text] [Related]
18. Red blood cell-based vaccines for ameliorating cancer chemoimmunotherapy.
Su L; Hao Y; Li R; Pan W; Ma X; Weng J; Min Y
Acta Biomater; 2022 Dec; 154():401-411. PubMed ID: 36241013
[TBL] [Abstract][Full Text] [Related]
19. Process of immunogenic cell death caused by disulfiram as the anti-colorectal cancer candidate.
You SY; Rui W; Chen ST; Chen HC; Liu XW; Huang J; Chen HY
Biochem Biophys Res Commun; 2019 Jun; 513(4):891-897. PubMed ID: 31003768
[TBL] [Abstract][Full Text] [Related]
20. On-Demand Autophagy Cascade Amplification Nanoparticles Precisely Enhanced Oxaliplatin-Induced Cancer Immunotherapy.
Wang X; Li M; Ren K; Xia C; Li J; Yu Q; Qiu Y; Lu Z; Long Y; Zhang Z; He Q
Adv Mater; 2020 Aug; 32(32):e2002160. PubMed ID: 32596861
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
